The performance of ICESi methods at medium-size networks with categorical features at the nodes; with selected data pre-processing for each algorithm: The average ARI index and its standard deviation
Mean SUCRA value, mean probability to be the best, and mean rank for each treatment based on total recovery, with the treatments in descending order of mean SUCRA.
Background The newly approved biologics and Janus kinase inhibitors (JAKi) for pediatric atopic dermatitis (AD) offer additional options for clinical treatment. However, the efficacy and safety differ
Additional file 4: Supplementary Table S1. Summary statistics of network meta-anaylsis estimates produced by BUGSnet package, applied to the data in Supplementary Data S1.
